gabexate has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamba, T; Fujiyama, Y; Nakamura, F; Saotome, T; Shintani, Y | 1 |
| Akita, K; Ikeda, K; Kaneda, K; Kawada, N; Kojima, S; Moriwaki, H; Okuno, M; Suzuki, Y | 1 |
| Iovanna, JL; Motoo, Y; Sawabu, N; Su, SB; Xie, MJ | 1 |
| Hirakawa, K; Maeda, K; Nishihara, T; Ohira, M; Sawada, T; Uchima, Y | 1 |
| Jia, D; Otsuki, M; Taguchi, M | 1 |
5 other study(ies) available for gabexate and transforming growth factor beta
| Article | Year |
|---|---|
Effects of synthetic serine protease inhibitors on proliferation and collagen synthesis of human pancreatic periacinar fibroblast-like cells.
Topics: Cell Division; Cells, Cultured; Collagen; Esters; Fibroblasts; Gabexate; Guanidines; Humans; Pancreas; Platelet-Derived Growth Factor; Proline; Serine Proteinase Inhibitors; Thymidine; Transforming Growth Factor beta; Tritium | 2001 |
Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
Topics: Animals; Cells, Cultured; Esters; Fibrinolysin; Gabexate; Guanidines; Liver Cirrhosis, Experimental; Male; Protease Inhibitors; Rats; Rats, Wistar; Transcriptional Activation; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator | 2001 |
Effect of camostat mesilate on the expression of pancreatitis-associated protein (PAP), p8, and cytokines in rat spontaneous chronic pancreatitis.
Topics: Acute-Phase Proteins; Animals; Antigens, Neoplasm; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Esters; Gabexate; Gene Expression; Growth Substances; Guanidines; Interleukin-6; Lectins, C-Type; Male; Neoplasm Proteins; Pancreatitis; Pancreatitis-Associated Proteins; Rats; Transforming Growth Factor beta | 2001 |
Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; Collagen; Drug Combinations; Enzyme Induction; Female; Gabexate; Gene Expression Regulation, Neoplastic; Humans; Laminin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Protease Inhibitors; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2004 |
Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Topics: Actins; Amylases; Animals; Atrophy; Eating; Esters; Fibrosis; Gabexate; Guanidines; Interleukin-6; Lipase; Male; Obesity; Organ Size; Pancreas; Pancreatitis, Chronic; Protease Inhibitors; Rats; Rats, Inbred OLETF; Receptor, Cholecystokinin A; Transforming Growth Factor beta; Trypsin; Tumor Necrosis Factor-alpha | 2005 |